Notably, in patients classified into phenogroup 5 (characterized by very old age, small LV size, and diastolic dysfunction), the prescription of beta-blockers or SGLT2 inhibitors was associated with an increased risk of adverse events, particularly hospitalization due to worsening HF. Here, SLC5A2 is linked to hydrops fetalis.